CCS Medical, a provider specializing in supporting patients with diabetes and chronic conditions, has launched CeeCee, an agentic artificial intelligence (AI) platform “in a comprehensive way across its enterprise operations.”
“Investment in these advanced tools helps streamline the patient experience, particularly during challenging times when an individual may be facing insurance changes, benefit shifts, and/or manufacturer inventory shortages,” CCS said in an April 28 news announcement. “Unlike what we are seeing across the industry — where reality has not yet caught up with the AI euphoria as most AI implementations are still at pilot-scale — CCS has already designed, developed and deployed a comprehensive and enterprise-wide agentic AI platform. This platform better serves complex patients at scale with measurable positive impact, including savings of more than 30% in annual operating costs.”
CeeCee was trained using CCS’s proprietary knowledge and data “to deliver empathetic, personalized support that resonates with the chronic are population the company services,” the news release added.
In its first four months of service, CeeCee is expected to independently handle 25% of incoming calls, which would also reduce call-handling times across the board.
The AI platform will also work to “autonomously identify and close documentation gaps that delay referrals or reorders for patients waiting for continuous glucose monitor (CGM) or insulin pump supplies. By the end of 2026, this capability is expected to automatically process 70% to 80% of the more than 100,000 monthly intake documents, accelerating order fulfillment and getting patients on therapy weeks sooner.”
And CeeCee will consolidate patient information, including call history and clinical context, when human agents need to step in to handle complex cases.
“CeeCee and our broader agentic AI platform aren’t pilots or a proof of concept — they are enterprise-grade solutions operating across our entire organization right now, autonomously handling patient interactions, accelerating care delivery, and freeing our teams to focus on what they do best: providing compassionate, personalized support for complex chronic patient needs,” said Richard Mackey, CCS’s chief technology officer.
“CCS’s platform shows how AI can deliver tangible results at scale today,” added Jean-Claude Saghbini, president of Lumeris Technology Solutions and technology advisor for CCS. “This is a new level of integration and patient-centric design that is rare — even amid rapid AI advancements happening today, especially in healthcare.”
Google Cloud describes agentic AI as “an advanced form of artificial intelligence focused on autonomous decision-making and action. Unlike traditional AI, which primarily responds to commands or analyzes data, agentic AI can set goals, plan and execute tasks with minimal human intervention.”
